Table 1.
No differences in selected in vivo characteristics
| Wild Type |
β-Actin KO |
|||
|---|---|---|---|---|
| Young Adult (8–13 wk old) | Mature Adult (18–23 wk old) | Young Adult (8–13 wk old) | Mature Adult (18–23 wk old) | |
| Male | ||||
| Body weight, g | 27.3 ± 0.61 | 33.0 ± 0.98 | 27.0 ± 0.46 | 33.1 ± 0.49 |
| MRI - fat mass, g | 2.42 ± 0.16 | 4.13 ± 0.56 | 2.16 ± 0.15 | 3.75 ± 0.36 |
| MRI - lean mass, g | 23.8 ± 0.52 | 28.1 ± 0.52 | 23.7 ± 0.51 | 28.4 ± 0.46 |
| Blood glucose, mmol/l | 15.5 ± 1.24 | 17.0 ± 1.47 | 17.1 ± 0.86 | 16.9 ± 0.82 |
| Insulin, ng/ml | 0.59 ± 0.05 | 1.31 ± 0.29 | 0.60 ± 0.05 | 1.25 ± 0.17 |
| Max running test, stop speed, m/s | 0.59 ± 0.02 | 0.56 ± 0.01 | 0.60 ± 0.02 | 0.57 ± 0.02 |
| Female | ||||
| Body weight, g | 20.1 ± 0.30 | 28.3 ± 0.97 | 20.3 ± 0.24 | 27.6 ± 0.58 |
| MRI - fat mass, g | 2.06 ± 0.12 | 5.33 ± 0.59 | 1.97 ± 0.11 | 5.01 ± 0.62 |
| MRI - lean mass, g | 17.1 ± 0.27 | 22.3 ± 0.43 | 16.9 ± 0.28 | 22.0 ± 0.27 |
| Blood glucose, mmol/l | 15.5 ± 1.72 | 15.6 ± 1.11 | 13.9 ± 0.76 | 17.8 ± 1.52 |
| Insulin, ng/ml | 0.45 ± 0.01 | 0.71 ± 0.08 | 0.55 ± 0.04 | 0.73 ± 0.05 |
| Max running test, stop speed, m/s | 0.55 ± 0.01 | 0.56 ± 0.02 | 0.54 ± 0.02 | 0.56 ± 0.02 |
All values are shown as means ± SE. Mice were injected with 2 g/kg body wt d-glucose for the intraperitoneal glucose tolerancew test. Blood glucose values are measured 20 min post-glucose injection together with a 50-µl blood sample to measure insulin levels. Young adult mice: 8–13 wk old, mature adult mice: 18–23 wk old; n = 9–10 mice.